800093

AstraZeneca Pharmaceuticals LP — FEI 3002617771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Frederick, MD (United States)